Affimed Therapeutics AG – Product Pipeline Review – 2012

Published : June 2012
No. of Pages : 43

Price:

Affimed Therapeutics AG – Product Pipeline Review – 2012

Summary

Global Market Direct’s pharmaceuticals report, “Affimed Therapeutics AG - Product Pipeline Review - 2012” provides data on the Affimed Therapeutics AG’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct’s proprietary databases, Affimed Therapeutics AG’s corporate website, SEC filings, investor presentations and featured press releases, both from Affimed Therapeutics AG and industry-specific third party sources, put together by Global Markets Direct’s team.

Scope

- Affimed Therapeutics AG - Brief Affimed Therapeutics AG overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Affimed Therapeutics AG human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of Affimed Therapeutics AG with complete description of the product’s developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the Affimed Therapeutics AG’s pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.

Reasons to buy

- Evaluate Affimed Therapeutics AG’s strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of Affimed Therapeutics AG in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the Affimed Therapeutics AG’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with Affimed Therapeutics AG.
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of Affimed Therapeutics AG and identify potential opportunities in those areas.

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
Affimed Therapeutics AG Snapshot 5
Affimed Therapeutics AG Overview 5
Key Information 5
Key Facts 5
Affimed Therapeutics AG – Research and Development Overview 6
Key Therapeutic Areas 6
Affimed Therapeutics AG – Pipeline Review 8
Pipeline Products by Stage of Development 8
Pipeline Products – Monotherapy 9
Affimed Therapeutics AG – Pipeline Products Glance 10
Affimed Therapeutics AG Clinical Stage Pipeline Products 10
Phase I Products/Combination Treatment Modalities 10
Affimed Therapeutics AG – Early Stage Pipeline Products 11
Pre-Clinical Products/Combination Treatment Modalities 11
Discovery Products/Combination Treatment Modalities 12
Affimed Therapeutics AG – Drug Profiles 13
AFM11 13
Product Description 13
Mechanism of Action 13
R&D Progress 13
AFM12 14
Product Description 14
Mechanism of Action 14
R&D Progress 14
AFM13 15
Product Description 15
Mechanism of Action 15
R&D Progress 15
AFM15 16
Product Description 16
Mechanism of Action 16
R&D Progress 16
AFM19 17
Product Description 17
Mechanism of Action 17
R&D Progress 17
AFM20 18
Product Description 18
Mechanism of Action 18
R&D Progress 18
AFM21 19
Product Description 19
Mechanism of Action 19
R&D Progress 19
Affimed Therapeutics AG – Pipeline Analysis 20
Affimed Therapeutics AG – Pipeline Products by Therapeutic Class 20
Affimed Therapeutics AG – Pipeline Products By Target 22
Affimed Therapeutics AG – Pipeline Products by Route of Administration 23
Affimed Therapeutics AG – Pipeline Products By Mechanism of Action 24
Affimed Therapeutics AG – Recent Pipeline Updates 26
Affimed Therapeutics AG - Dormant Projects 27
Affimed Therapeutics AG – Locations And Subsidiaries 28
Head Office 28
Financial Deals Landscape 29
Affimed Therapeutics AG, Deals Summary 29
Affimed Therapeutics AG, Pharmaceuticals & Healthcare, Deal Details 30
Venture Financing 30
Affimed Therapeutics Raises $26.4 Million In Series C Financing 30
Affimed Therapeutics Raises $45 Million In Series B Financing 32
Affimed Therapeutics Raises $3.9 Million In Financing 34
Partnerships 36
Probiogen Enters Into Agreement With Affimed Therapeutics 36
Affimed Therapeutics Enters Into Co-Development Agreement With Syngenta 37
Licensing Agreements 38
XOMA Enters Into Licensing Agreement With Affimed Therapeutics 38
Affimed Therapeutics Enters Into Licensing Agreement With XOMA 39
Affimed Therapeutics Enters Into Licensing Agreement With InNexus Biotech 40
InNexus Biotech Enters Into Licensing Agreement With Affimed Therapeutics 41
Appendix 42
Methodology 42
Coverage 42
Secondary Research 42
Primary Research 42
Expert Panel Validation 42
Contact Us 43
Disclaimer 43

List of Tables
Affimed Therapeutics AG, Key Information 5
Affimed Therapeutics AG, Key Facts 5
Affimed Therapeutics AG – Pipeline by Indication, 2012 7
Affimed Therapeutics AG – Pipeline by Stage of Development, 2012 8
Affimed Therapeutics AG – Monotherapy Products in Pipeline, 2012 9
Affimed Therapeutics AG – Phase I, 2012 10
Affimed Therapeutics AG – Pre-Clinical, 2012 11
Affimed Therapeutics AG – Discovery, 2012 12
Affimed Therapeutics AG – Pipeline By Therapeutic Class, 2012 21
Affimed Therapeutics AG - Pipeline By Target, 2012 22
Affimed Therapeutics AG – Pipeline By Route of Administration, 2012 23
Affimed Therapeutics AG – Pipeline Products By Mechanism of Action, 2012 25
Affimed Therapeutics AG – Recent Pipeline Updates, 2012 26
Affimed Therapeutics AG - Dormant Developmental Projects,2012 27
Affimed Therapeutics AG, Deals Summary 29
Affimed Therapeutics Raises $26.4 Million In Series C Financing 30
Affimed Therapeutics Raises $45 Million In Series B Financing 32
Affimed Therapeutics Raises $3.9 Million In Financing 34
Probiogen Enters Into Agreement With Affimed Therapeutics 36
Affimed Therapeutics Enters Into Co-Development Agreement With Syngenta 37
XOMA Enters Into Licensing Agreement With Affimed Therapeutics 38
Affimed Therapeutics Enters Into Licensing Agreement With XOMA 39
Affimed Therapeutics Enters Into Licensing Agreement With InNexus Biotech 40
InNexus Biotech Enters Into Licensing Agreement With Affimed Therapeutics 41

List of Figures
Affimed Therapeutics AG – Pipeline by Indication, 2012 7
Affimed Therapeutics AG – Pipeline by Stage of Development, 2012 8
Affimed Therapeutics AG – Monotherapy Products in Pipeline, 2012 9
Affimed Therapeutics AG – Pipeline By Therapeutic Class, 2012 20
Affimed Therapeutics AG - Pipeline By Target, 2012 22
Affimed Therapeutics AG - Pipeline Products By Mechanism of Action, 2012 24

Affimed Therapeutics AG – Product Pipeline Review – 2012

Published By: Global Markets Direct

Price:

How to Purchase

Purchase products from our site in 5 easy steps. Please follow the description given below to complete your purchase process.

Step 1:

Select the report title of your interest, and Click on Buy Now button next to the Price option.

Step 2:

You will arrive at the Purchase page, where you will be requested to Signup (New User) or Login (Registered User). Please note that in-keeping with the security check on the website, you must submit your full details to avoid any inconvenience arising from incorrectly entered data or counterfeit information.

Step 3:

After SignUp/Login, you will arrive at the Online Invoice Page. Select a Payment option via various methods: Debit Card / Credit Card / by Invoice. MarketReportOnline accepts Visa, MasterCard, American Express and all major credit cards. MarketReportOnline uses ICICI, HDFC, Citibank, American Express & Paypal as our Online Payment Gateway Partners. Clicking on a payment option will take you to the corresponding Payment Gateway page.

Step 4:

Once at the Payment Gateway, please complete the Payment Process to purchase your desired report.

Step 5:

Once you have successfully completed the purchase process, you will receive a confirmation email. You will then either be able to download your report immediately (in PDF Format) from the Account Login button, or the report will be emailed to you directly, depending upon the agreement we have with the publisher. For Orders that are deliverable via email and placed after working hours, the delivery of the reports will be made on the next business day. Please note, if you select purchase by invoice, you will receive your report only once the payment has been received. If you have any queries about how to order, please Contact Us .

sales@marketreportsonline.com + 1 888 391 5441

Using our subscription option, you get access to market research reports and industry data of Industry Profiles market as per your needs. Get the best of Industry Profiles research reports by utilizing your research budgets in an optimum way.
More about our Subscription option

Get Email alerts about market research reports from industries and publishers of your interest: